Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

医学 内科学 危险系数 微小残留病 造血干细胞移植 肿瘤科 比例危险模型 国际预后积分系统 移植 骨髓增生异常综合症 骨髓 置信区间
作者
Magnus Tobiasson,Tatjana Pandzic,Johanna Illman,Lars Nilsson,Simone Weström,Elisabeth Ejerblad,G. Olesen,Andreas T. Björklund,Astrid Olsnes Kittang,Olle Werlenius,Fryderyk Lorentz,Bengt Rasmussen,Jörg Cammenga,Duruta Weber,Carolin Lindholm,Joel Wiggh,Marios Dimitriou,Ann Elin Moen,Laimei Yip Lundström,Lena von Bahr,Karin Baltzer-Sollander,Martin Jädersten,Soili Kytölä,Gunilla Walldin,Per Ljungman,Kirsten Groenbaek,Stephan Mielke,Sten Eirik W. Jacobsen,Freja Ebeling,Lucia Cavelier,Lone Smidstrup Friis,Ingunn Dybedal,Eva Hellström‐Lindberg
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:42 (12): 1378-1390 被引量:8
标识
DOI:10.1200/jco.23.01159
摘要

PURPOSE Clinical relapse is the major threat for patients with myelodysplastic syndrome (MDS) undergoing hematopoietic stem-cell transplantation (HSCT). Early detection of measurable residual disease (MRD) would enable preemptive treatment and potentially reduced relapse risk. METHODS Patients with MDS planned for HSCT were enrolled in a prospective, observational study evaluating the association between MRD and clinical outcome. We collected bone marrow (BM) and peripheral blood samples until relapse, death, or end of study 24 months after HSCT. Patient-specific mutations were identified with targeted next-generation sequencing (NGS) panel and traced using droplet digital polymerase chain reaction (ddPCR). RESULTS Of 266 included patients, estimated relapse-free survival (RFS) and overall survival (OS) rates 3 years after HSCT were 59% and 64%, respectively. MRD results were available for 221 patients. Relapse was preceded by positive BM MRD in 42/44 relapses with complete MRD data, by a median of 71 (23-283) days. Of 137 patients in continuous complete remission, 93 were consistently MRD-negative, 39 reverted from MRD+ to MRD–, and five were MRD+ at last sampling. Estimated 1 year-RFS after first positive MRD was 49%, 39%, and 30%, using cutoff levels of 0.1%, 0.3%, and 0.5%, respectively. In a multivariate Cox model, MRD (hazard ratio [HR], 7.99), WHO subgroup AML (HR, 4.87), TP53 multi-hit (HR, 2.38), NRAS (HR, 3.55), and acute GVHD grade III-IV (HR, 4.13) were associated with shorter RFS. MRD+ was also independently associated with shorter OS (HR, 2.65). In a subgroup analysis of 100 MRD+ patients, presence of chronic GVHD was associated with longer RFS (HR, 0.32). CONCLUSION Assessment of individualized MRD using NGS + ddPCR is feasible and can be used for early detection of relapse. Positive MRD is associated with shorter RFS and OS (ClinicalTrials.gov identifier: NCT02872662 ).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FOX发布了新的文献求助10
刚刚
刚刚
Lmmm完成签到,获得积分10
刚刚
刚刚
1秒前
1秒前
syvshc的应助被zezeze采纳,获得10
1秒前
香蕉觅云的应助被Pepsi采纳,获得10
1秒前
柠栀发布了新的文献求助10
1秒前
龙1完成签到,获得积分10
2秒前
2秒前
orixero的应助被激情的随阴采纳,获得10
2秒前
优秀的微笑完成签到,获得积分10
2秒前
Still发布了新的文献求助20
3秒前
赘婿的应助被张琪采纳,获得10
3秒前
zzzz发布了新的文献求助10
3秒前
3秒前
田様的应助被12121采纳,获得10
3秒前
4秒前
刘淑蕊发布了新的文献求助10
4秒前
4秒前
纯真方盒完成签到,获得积分10
4秒前
科研通AI6.2的应助被落叶采纳,获得10
4秒前
5秒前
5秒前
5秒前
爆米花的应助被causl采纳,获得10
6秒前
che完成签到,获得积分10
6秒前
6秒前
6秒前
orixero的应助被WUWUWUUW采纳,获得10
7秒前
思源的应助被皮不可采纳,获得10
7秒前
四火发布了新的文献求助10
7秒前
Simon完成签到,获得积分10
7秒前
orixero的应助被凶狠的碧采纳,获得10
8秒前
Yi完成签到,获得积分10
8秒前
bai发布了新的文献求助10
8秒前
8秒前
汉堡包的应助被wengarak采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8169168
求助须知:如何正确求助?哪些是违规求助? 9562182
关于积分的说明 21764903
捐赠科研通 7760775
什么是DOI,文献DOI怎么找? 3430228
关于科研通互助平台的介绍 2554080
邀请新用户注册赠送积分活动 2474932